Literature DB >> 6840819

Structural and functional changes in cerebral arteries from spontaneously hypertensive rats.

R J Winquist, D F Bohr.   

Abstract

Segments of basilar arteries from both spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto (WKY) rats were studied in vitro utilizing a microvessel apparatus. At similar levels of passive force, basilar arteries from SHR developed less force in response to depolarizing solution (130 mM K+) compared to basilar arteries from WKY. Arterial segments from the hypertensive animals required less stretch to achieve each level of passive force. Basilar arteries from SHR but not WKY typically displayed both phasic and tonic spontaneous activity which was inhibited in a reversible manner by washing the tissues in physiological salt solution without added Ca++ (EGTA, 1 mM). There was a significant shift to the left in the EC50 of serotonin and a greater maximal response to this agonist in basilar arteries from SHR compared to those from WKY (p less than 0.01). The EC50 to Ca++ (added to a depolarizing solution) was shifted to the right in the arteries from SHR compared to the normotensive controls (p less than 0.05). There was no difference between the arteries from the two groups of animals in the relaxation response produced by isoproterenol. However, contracted basilar arteries from SHR were less sensitive to the relaxant effects of elevated Ca++ than contracted basilar arteries from WKY (p less than 0.05). These results demonstrate the existence of both structural and functional difference between cerebral vessels of SHR and WKY. Our findings also demonstrate the complex nature of the changes in calcium dynamics in blood vessels from hypertensive animals.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6840819     DOI: 10.1161/01.hyp.5.3.292

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  12 in total

Review 1.  Angiotensin and cerebral blood flow.

Authors:  J M Saavedra; Y Nishimura
Journal:  Cell Mol Neurobiol       Date:  1999-10       Impact factor: 5.046

2.  Characterization of 5-hydroxytryptamine receptors mediating contractions in basilar arteries from stroke-prone spontaneously hypertensive rats.

Authors:  Y Nishimura
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

3.  Hepoxilins sensitize blood vessels to noradrenaline--stereospecificity of action.

Authors:  O Laneuville; R Couture; C R Pace-Asciak
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

4.  Role of iNOS in the vasodilator responses induced by L-arginine in the middle cerebral artery from normotensive and hypertensive rats.

Authors:  A M Briones; M J Alonso; J Marín; M Salaices
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

Review 5.  Neurovascular signaling in the brain and the pathological consequences of hypertension.

Authors:  Kathryn M Dunn; Mark T Nelson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-10-25       Impact factor: 4.733

6.  Possible mechanism of the potent vasoconstrictor actions of ryanodine on femoral arteries from spontaneously hypertensive rats.

Authors:  M Asano; M Kuwako; Y Nomura; K M Ito; K Ito; Y Uyama; Y Imaizumi; M Watanabe
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

7.  Charybdotoxin-sensitive K+ channels regulate the myogenic tone in the resting state of arteries from spontaneously hypertensive rats.

Authors:  M Asano; K Masuzawa-Ito; T Matsuda
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

8.  Composition and mechanics of cerebral arterioles in hypertensive rats.

Authors:  G L Baumbach; J G Walmsley; M N Hart
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

9.  Vasopressin induced rhythmic activity in rat basilar artery.

Authors:  N J Rusch; K Hermsmeyer
Journal:  Ann Biomed Eng       Date:  1985       Impact factor: 3.934

Review 10.  Hypertension, dietary salt and cognitive impairment.

Authors:  Monica M Santisteban; Costantino Iadecola
Journal:  J Cereb Blood Flow Metab       Date:  2018-10-08       Impact factor: 6.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.